First man in Britain receives pioneering lung cancer vaccine - amid worrying rise of disease in young, never-smokers READ MORE: The rise of 'super-fit' slim young people with bowel cancer By Emily Stearn, Health Reporter For Mailonline Published: 09:24, 23 August 2024 | Updated: 09:25, 23 August 2024 e-mail View comments A man whose deadly lung cancer was discovered 'by coincidence' has become the first in the UK to receive a 'game-changing' vaccine. Janusz Racz, from London , was given a heartbreaking diagnosis of just four to five months to live in May after the disease was spotted during a colonoscopy. Told chemotherapy and radiotherapy would only give the scientist, 67, a 35 per cent chance of surviving over five years, he then opted to take part in a pioneering trial of the jab.
The vaccine, codenamed BNT116, is made by BioNTech using the same mRNA technology that underpinned its highly effective Covid jab. Doctors believe the treatment — which is custom built for patients to stop their cancer returning — will herald a new era in fighting the disease. Janusz Racz, from London , was given a heartbreaking diagnosis of just four to five months to live in May after the disease was spotted during a colonoscopy Told chemotherapy and radiotherapy would only give the scientist, 67, a 35 per cent chance of surviving over five years, he then opted to take part in the pioneering trial Designed to treat non-small cell lung cancer (NSCLC), the most common form of the disease, the.